| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |